Navigation Links
Rigel Announces Fourth Quarter and Year End 2011 Financial Results
Date:3/6/2012

studies with R348 by the end of 2012.  
  • R256, inhaled interleukin 13 (IL13) signaling inhibitor for chronic asthma.  This selective and potent IL13 inhibitor is in preclinical studies aimed at evaluating its ability to reduce airway inflammation generally associated with chronic asthma and potentially improve the health of the lungs.
  • Intravenous inhibition of GDF8 signaling for muscle strength.  One of Rigel's programs aimed at muscle health, this preclinical program is focused on inhibiting the GDF8 signaling cascade which leads to loss of muscle in a variety of chronic disease states, but particularly in regard to loss of diaphragm muscle mass and strength (atrophy) associated with respiratory ventilator use.  Preclinical studies have shown that inhibiting GDF8 signaling may be therapeutically useful to prevent muscle loss and improve muscle function.  
  • Oral AMP-activated Kinase (AMPK) activation for muscle endurance.  Patients with chronic illnesses such as chronic heart failure, COPD or diabetes, often experience a decrease in strength and increase in fatigue due to muscle myopathy.  Rigel is conducting preclinical studies of an oral activator of AMPK to improve the body's energy utilization and restore muscle endurance in chronically ill subjects.  

  • About Rigel (www.rigel.com)

    Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 c
    '/>"/>

    SOURCE Rigel Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Rigel Announces Participation at Two Investor Conferences
    2. Rigel Announces Initiation of Clinical Trials in Two Immunology Programs
    3. Rigel to Present at Oppenheimer Annual Healthcare Conference
    4. Rigel Announces Third Quarter 2011 Financial Results
    5. Rigel to Present at Two Upcoming Investor Conferences
    6. Rigel to Present at Wells Fargo Securities Healthcare Conference
    7. Rigel to Present at Jefferies Global Healthcare Conference
    8. Rigel Announces Pricing of Public Offering of Common Stock
    9. Rigel Announces Proposed Public Offering of Common Stock
    10. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
    11. Rigel Announces First Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
    (Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
    (Date:1/22/2015)... Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today announced ... financial results on Tuesday, Jan. 27, 2015, after the close of ... conference call with the investment community at 2 p.m. PT. Participating ... , chairman and chief executive officer, and other members of Amgen,s ...
    Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
    ... South Dakota pharmaceutical company, pharmaCline ™ , has launched ... statement.  On November 23, 2011, pharmaCline became a part ... spot on the CBS jumbo screen located in Times ... through January 1, 2012. (Logo:  http://photos.prnewswire.com/prnh/20111202/MN16158LOGO ...
    ... Dec. 1, 2011 Demands from senior management ... commercial functions searching for best-in-class organizational structures. Comparing ... in place at peer companies through benchmarking data ... To support pharmaceutical vice presidents, directors, ...
    Cached Medicine Technology:pharmaCline Launches "pharmaCline Can Help" Campaign 2Organizational Design and Structure Benchmarks for Pharmaceutical Commercial Functions Accessed Quickly Through Best Practices, LLC's New Database Search Function 2
    (Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
    (Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many trendy ... on Facebook, Twitter, and Pinterest. The fans will have an ... lottery every week. , Moreover, the company has extended its ... Angelweddingdress homepage for more information. , Angelweddingdress is ...
    (Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
    (Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
    (Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
    Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
    ... children need to discuss sexual matters sooner, researchers say ... comes to talking about sex, parents are a few ... conversation occurs after, and not before, kids start experimenting ... the January issue of Pediatrics . , This ...
    ... , WASHINGTON, Dec. 7 Hoping to protect their ... across the country are prepared to make the difficult choices ... , This becomes clear in a report released today by ... Stewardship Project. Supported by a grant from the Peter G. ...
    ... ... 7 NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ), a leading ... the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the ... , The presentation is scheduled to be web cast live on the Company Web ...
    ... , WALTHAM, Mass., Dec. 7 Interleukin Genetics, ... received approval by the State of New York,s Department of ... PST Genetic Test that determines predisposition to severe periodontal disease ... other States in the U.S. However, through its Clinical ...
    ... ... community developed by, and dedicated to, persons with illnesses and disabilities to establish a ... and situations while maintaining as much, or as little privacy as desired. , ... Milwaukee, WI (PRWEB) December ...
    ... , ANN ARBOR, Mich., Dec. ... Micromedex 2.0, the newest version of its market-leading clinical ... than 3,500 hospitals in 83 countries use Micromedex, which ... dosing, alternative medicines, and patient education. , The new ...
    Cached Medicine News:Health News:Sex Talk Taking Place After the Fact 2Health News:Sex Talk Taking Place After the Fact 3Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 3Health News:NBTY To Webcast Presentation; Wedbush Securities California Dreamin' Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009 2Health News:NBTY To Webcast Presentation; Wedbush Securities California Dreamin' Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009 3Health News:NBTY To Webcast Presentation; Wedbush Securities California Dreamin' Mac Conference; Announces Preliminary Unaudited Net Sales Results For November 2009 4Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 2Health News:Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Thomson Reuters Releases Micromedex 2.0 2Health News:Thomson Reuters Releases Micromedex 2.0 3
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: